TrialJournal of virology2012

HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.

Opass Putcharoen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.